Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.
A deep learning model that leverages interpretable cellular features to improve feature extraction from H&E-stained tissue sections (NEURAL-PC) and represents an extensively validated diagnostic and prognostic model for advanced prostate cancer.